Literature DB >> 18224418

A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22).

Keiki Kawakami1, Kazuhiro Nishii, Ryuu Hyou, Yasuyuki Watanabe, Makoto Nakao, Hidetsugu Mitani, Tetsuya Murata, Fumihiko Monma, Shunji Yamamori, Noboru Hosokai, Ikuo Miura.   

Abstract

We encountered a case of acute myeloblastic leukemia (AML), with extramedullary leukemia (EML) and a masked type of the variant translocation t(8;21)(q22;q22). Morphologically, the AML M2 subtype according to the French-American-British (FAB) classification was present. Phenotypically, leukemic cells were negative for CD19 and positive for CD56. Clinically, the case showed chemo-refractoriness and a poor outcome. The initial karyotypic interpretation was t(8;9)(q22;q34) on G-banding. Multiplex-fluorescence in situ hybridization (multiplex-FISH) analysis revealed a three-way translocation involving chromosomes 8, 9, and 21, and identified a masked type of variant t(8;21)q22;q22) translocation. The karyotype was finally determined as 45,X,-Y,der(8)t(8;21)(q22;q22), der(9)(8;9)(q22;q34), and der(21)t(9;21)(q34;q22). Results of FISH using the AML1/ETO probe and detection of the AML1/ETO fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) support the karyotype as well as the sequence of the PCR product. Additionally, C-KIT mutation was detected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18224418     DOI: 10.1007/s12185-007-0010-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR.

Authors:  Kazuoki Osumi; Takafumi Fukui; Hitoshi Kiyoi; Masanobu Kasai; Yoshihisa Kodera; Kazuko Kudo; Koji Kato; Takaharu Matsuyama; Kazuyuki Naito; Mitsune Tanimoto; Hisamaru Hirai; Hidehiko Saito; Ryuzo Ohno; Tomoki Naoe
Journal:  Leuk Lymphoma       Date:  2002-12

2.  Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase.

Authors:  Rowan Foster; Renate Griffith; Petranel Ferrao; Leonie Ashman
Journal:  J Mol Graph Model       Date:  2004-10       Impact factor: 2.518

3.  Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.

Authors:  K Nishii; E Usui; N Katayama; F Lorenzo; K Nakase; T Kobayashi; H Miwa; M Mizutani; I Tanaka; K Nasu; H Dohy; T Kyo; M Taniwaki; T Ueda; K Kita; H Shiku
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

4.  Two cases of AML (M2) with a t(8;19)(q22;q13): a new cytogenetic variant.

Authors:  Y Xue; C Niu; S Chen; Y Wang; Y Guo; X Xie; D Lu; P Li
Journal:  Cancer Genet Cytogenet       Date:  2000-04-15

5.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

6.  Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).

Authors:  L Vieira; V Oliveira; A P Ambrósio; B Marques; A M Pereira; A Hagemeijer; M G Boavida
Journal:  Cancer Genet Cytogenet       Date:  2001-07-15

7.  Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia.

Authors:  J M Trujillo; A Cork; M J Ahearn; E L Youness; K B McCredie
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

8.  Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.

Authors:  Roberto Cairoli; Alessandro Beghini; Giovanni Grillo; Gianpaolo Nadali; Francesca Elice; Carla Barbara Ripamonti; Patrizia Colapietro; Michele Nichelatti; Laura Pezzetti; Monia Lunghi; Antonio Cuneo; Assunta Viola; Felicetto Ferrara; Mario Lazzarino; Francesco Rodeghiero; Giovanni Pizzolo; Lidia Larizza; Enrica Morra
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

9.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.

Authors:  T Miyamoto; I L Weissman; K Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Authors:  C D Bloomfield; D Lawrence; J C Byrd; A Carroll; M J Pettenati; R Tantravahi; S R Patil; F R Davey; D T Berg; C A Schiffer; D C Arthur; R J Mayer
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

View more
  1 in total

1.  Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML).

Authors:  Lindsay Wilde; Jillian Cooper; Zi-Xuan Wang; Jinglan Liu
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.